Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane.
Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW.
Chin BB, et al. Among authors: james og.
J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13.
J Nucl Med. 2014.
PMID: 24627436
Free article.
Clinical Trial.